Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
NDSN vs ITW vs EMR vs GGG vs ROK
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
NDSN vs ITW vs EMR vs GGG vs ROK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $15.83B | $73.64B | $79.02B | $13.06B | $50.37B |
| Revenue (TTM) | $2.85B | $16.22B | $18.32B | $2.25B | $8.80B |
| Net Income (TTM) | $523M | $3.13B | $2.44B | $516M | $1.09B |
| Gross Margin | 55.2% | 44.1% | 52.7% | 52.3% | 52.5% |
| Operating Margin | 25.9% | 26.4% | 19.8% | 26.9% | 19.1% |
| Forward P/E | 24.9x | 22.7x | 21.7x | 25.2x | 36.9x |
| Total Debt | $2.09B | $8.97B | $13.76B | $61M | $3.65B |
| Cash & Equiv. | $108M | $851M | $1.54B | $624M | $468M |
NDSN vs ITW vs EMR vs GGG vs ROK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nordson Corporation (NDSN) | 100 | 150.9 | +50.9% |
| Illinois Tool Works… (ITW) | 100 | 148.2 | +48.2% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Graco Inc. (GGG) | 100 | 163.2 | +63.2% |
| Rockwell Automation… (ROK) | 100 | 207.4 | +107.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NDSN vs ITW vs EMR vs GGG vs ROK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NDSN ranks third and is worth considering specifically for valuation efficiency.
- PEG 1.68 vs EMR's 4.81
- Lower P/E (24.9x vs 36.9x)
ITW carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 0.67, yield 2.4%
- Beta 0.67, yield 2.4%, current ratio 1.21x
- Beta 0.67 vs EMR's 1.52
- 2.4% yield, 12-year raise streak, vs EMR's 1.5%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
GGG is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 5.8%, EPS growth 9.2%, 3Y rev CAGR 1.4%
- Lower volatility, beta 0.80, Low D/E 2.3%, current ratio 3.15x
- 5.8% revenue growth vs ITW's 0.9%
- 23.0% margin vs ROK's 12.4%
ROK is the clearest fit if your priority is long-term compounding.
- 341.0% 10Y total return vs NDSN's 298.2%
- +60.2% vs GGG's -2.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.8% revenue growth vs ITW's 0.9% | |
| Value | Lower P/E (24.9x vs 36.9x) | |
| Quality / Margins | 23.0% margin vs ROK's 12.4% | |
| Stability / Safety | Beta 0.67 vs EMR's 1.52 | |
| Dividends | 2.4% yield, 12-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +60.2% vs GGG's -2.6% | |
| Efficiency (ROA) | 19.4% ROA vs EMR's 5.8%, ROIC 29.0% vs 8.2% |
NDSN vs ITW vs EMR vs GGG vs ROK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NDSN vs ITW vs EMR vs GGG vs ROK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GGG leads in 1 of 6 categories
EMR leads 1 • ROK leads 1 • NDSN leads 0 • ITW leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GGG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 8.1x GGG's $2.2B. GGG is the more profitable business, keeping 23.0% of every revenue dollar as net income compared to ROK's 12.4%. On growth, ROK holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.8B | $16.2B | $18.3B | $2.2B | $8.8B |
| EBITDAEarnings before interest/tax | $851M | $4.6B | $4.7B | $690M | $1.9B |
| Net IncomeAfter-tax profit | $523M | $3.1B | $2.4B | $516M | $1.1B |
| Free Cash FlowCash after capex | $646M | $2.2B | $3.1B | $631M | $1.3B |
| Gross MarginGross profit ÷ Revenue | +55.2% | +44.1% | +52.7% | +52.3% | +52.5% |
| Operating MarginEBIT ÷ Revenue | +25.9% | +26.4% | +19.8% | +26.9% | +19.1% |
| Net MarginNet income ÷ Revenue | +18.4% | +19.3% | +13.3% | +23.0% | +12.4% |
| FCF MarginFCF ÷ Revenue | +22.7% | +13.6% | +17.0% | +28.1% | +15.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.8% | +4.6% | +2.9% | +2.2% | +11.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +44.2% | +11.8% | +28.2% | -2.8% | +39.6% |
Valuation Metrics
EMR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 24.4x trailing earnings, ITW trades at a 58% valuation discount to ROK's 58.5x P/E. Adjusting for growth (PEG ratio), NDSN offers better value at 2.26x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $15.8B | $73.6B | $79.0B | $13.1B | $50.4B |
| Enterprise ValueMkt cap + debt − cash | $17.8B | $81.8B | $91.2B | $12.5B | $53.6B |
| Trailing P/EPrice ÷ TTM EPS | 33.39x | 24.36x | 34.92x | 25.54x | 58.45x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.86x | 22.68x | 21.71x | 25.15x | 36.93x |
| PEG RatioP/E ÷ EPS growth rate | 2.26x | 2.53x | 7.73x | 2.58x | — |
| EV / EBITDAEnterprise value multiple | 20.66x | 17.74x | 18.07x | 17.40x | 30.64x |
| Price / SalesMarket cap ÷ Revenue | 5.67x | 4.59x | 4.39x | 5.84x | 6.04x |
| Price / BookPrice ÷ Book value/share | 5.31x | 23.15x | 3.94x | 5.02x | 13.66x |
| Price / FCFMarket cap ÷ FCF | 23.94x | 27.20x | 29.63x | 20.47x | 37.09x |
Profitability & Efficiency
Evenly matched — ITW and GGG each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ITW delivers a 97.4% return on equity — every $100 of shareholder capital generates $97 in annual profit, vs $12 for EMR. GGG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITW's 2.78x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs GGG's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.8% | +97.4% | +12.1% | +19.7% | +29.6% |
| ROA (TTM)Return on assets | +10.2% | +19.4% | +5.8% | +16.0% | +9.7% |
| ROICReturn on invested capital | +10.5% | +29.0% | +8.2% | +22.6% | +15.1% |
| ROCEReturn on capital employed | +13.4% | +38.7% | +10.0% | +22.0% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.69x | 2.78x | 0.68x | 0.02x | 0.98x |
| Net DebtTotal debt minus cash | $2.0B | $8.1B | $12.2B | -$563M | $3.2B |
| Cash & Equiv.Liquid assets | $108M | $851M | $1.5B | $624M | $468M |
| Total DebtShort + long-term debt | $2.1B | $9.0B | $13.8B | $61M | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | 7.44x | 14.53x | 6.46x | 209.82x | 9.06x |
Total Returns (Dividends Reinvested)
ROK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ROK five years ago would be worth $17,462 today (with dividends reinvested), compared to $10,636 for GGG. Over the past 12 months, ROK leads with a +60.2% total return vs GGG's -2.6%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs GGG's 1.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.2% | +3.1% | +4.3% | -4.1% | +12.8% |
| 1-Year ReturnPast 12 months | +51.8% | +9.0% | +30.4% | -2.6% | +60.2% |
| 3-Year ReturnCumulative with dividends | +34.5% | +19.5% | +75.9% | +4.5% | +65.0% |
| 5-Year ReturnCumulative with dividends | +42.4% | +18.9% | +59.5% | +6.4% | +74.6% |
| 10-Year ReturnCumulative with dividends | +298.2% | +189.4% | +206.6% | +228.8% | +341.0% |
| CAGR (3Y)Annualised 3-year return | +10.4% | +6.1% | +20.7% | +1.5% | +18.2% |
Risk & Volatility
Evenly matched — ITW and ROK each lead in 1 of 2 comparable metrics.
Risk & Volatility
ITW is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 96.7% from its 52-week high vs GGG's 82.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 0.67x | 1.52x | 0.80x | 1.33x |
| 52-Week HighHighest price in past year | $305.28 | $303.16 | $165.15 | $95.69 | $463.49 |
| 52-Week LowLowest price in past year | $188.22 | $236.68 | $108.37 | $77.70 | $277.66 |
| % of 52W HighCurrent price vs 52-week peak | +93.1% | +84.3% | +85.4% | +82.2% | +96.7% |
| RSI (14)Momentum oscillator 0–100 | 59.3 | 45.3 | 61.3 | 40.0 | 74.9 |
| Avg Volume (50D)Average daily shares traded | 306K | 1.2M | 2.8M | 1.1M | 831K |
Analyst Outlook
Evenly matched — NDSN and ITW and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NDSN as "Buy", ITW as "Hold", EMR as "Buy", GGG as "Hold", ROK as "Hold". Consensus price targets imply 21.6% upside for GGG (target: $96) vs -2.6% for ROK (target: $437). For income investors, ITW offers the higher dividend yield at 2.39% vs NDSN's 1.11%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $311.50 | $273.67 | $161.92 | $95.67 | $436.56 |
| # AnalystsCovering analysts | 20 | 28 | 41 | 20 | 39 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +2.4% | +1.5% | +1.4% | +1.2% |
| Dividend StreakConsecutive years of raises | 37 | 12 | 37 | 20 | 20 |
| Dividend / ShareAnnual DPS | $3.15 | $6.11 | $2.10 | $1.08 | $5.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.9% | +2.0% | +1.6% | +3.2% | +0.8% |
GGG leads in 1 of 6 categories (Income & Cash Flow). EMR leads in 1 (Valuation Metrics). 3 tied.
NDSN vs ITW vs EMR vs GGG vs ROK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NDSN or ITW or EMR or GGG or ROK a better buy right now?
For growth investors, Graco Inc.
(GGG) is the stronger pick with 5. 8% revenue growth year-over-year, versus 0. 9% for Illinois Tool Works Inc. (ITW). Illinois Tool Works Inc. (ITW) offers the better valuation at 24. 4x trailing P/E (22. 7x forward), making it the more compelling value choice. Analysts rate Nordson Corporation (NDSN) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NDSN or ITW or EMR or GGG or ROK?
On trailing P/E, Illinois Tool Works Inc.
(ITW) is the cheapest at 24. 4x versus Rockwell Automation, Inc. at 58. 5x. On forward P/E, Emerson Electric Co. is actually cheaper at 21. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nordson Corporation wins at 1. 68x versus Emerson Electric Co. 's 4. 81x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NDSN or ITW or EMR or GGG or ROK?
Over the past 5 years, Rockwell Automation, Inc.
(ROK) delivered a total return of +74. 6%, compared to +6. 4% for Graco Inc. (GGG). Over 10 years, the gap is even starker: ROK returned +341. 0% versus ITW's +189. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NDSN or ITW or EMR or GGG or ROK?
By beta (market sensitivity over 5 years), Illinois Tool Works Inc.
(ITW) is the lower-risk stock at 0. 67β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 127% more volatile than ITW relative to the S&P 500. On balance sheet safety, Graco Inc. (GGG) carries a lower debt/equity ratio of 2% versus 3% for Illinois Tool Works Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NDSN or ITW or EMR or GGG or ROK?
By revenue growth (latest reported year), Graco Inc.
(GGG) is pulling ahead at 5. 8% versus 0. 9% for Illinois Tool Works Inc. (ITW). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -10. 4% for Illinois Tool Works Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NDSN or ITW or EMR or GGG or ROK?
Graco Inc.
(GGG) is the more profitable company, earning 23. 3% net margin versus 10. 4% for Rockwell Automation, Inc. — meaning it keeps 23. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GGG leads at 27. 3% versus 17. 1% for ROK. At the gross margin level — before operating expenses — NDSN leads at 55. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NDSN or ITW or EMR or GGG or ROK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Nordson Corporation (NDSN) is the more undervalued stock at a PEG of 1. 68x versus Emerson Electric Co. 's 4. 81x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Emerson Electric Co. (EMR) trades at 21. 7x forward P/E versus 36. 9x for Rockwell Automation, Inc. — 15. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GGG: 21. 6% to $95. 67.
08Which pays a better dividend — NDSN or ITW or EMR or GGG or ROK?
All stocks in this comparison pay dividends.
Illinois Tool Works Inc. (ITW) offers the highest yield at 2. 4%, versus 1. 1% for Nordson Corporation (NDSN).
09Is NDSN or ITW or EMR or GGG or ROK better for a retirement portfolio?
For long-horizon retirement investors, Illinois Tool Works Inc.
(ITW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67), 2. 4% yield, +189. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ITW: +189. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NDSN and ITW and EMR and GGG and ROK?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.